B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | WebDisclosure

Basculer en Français

10406	Companies
217558	Keywords
147132	Articles
115135	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

PRESS RELEASE

published on 10/31/2024 at 19:20, 1 year 6 months ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 1 year 6 months ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
BRIEF

published on 10/31/2024 at 19:16, 1 year 6 months ago

BRAIN Biotech AG conclut un accord de licence avec Akribion Therapeutics

Redevance Licences Biotechnologiques Technologie CRISPR-Cas Accord Pharmaceutique Frais D'étape
PRESS RELEASE

published on 10/31/2024 at 19:11, 1 year 6 months ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 1 year 7 months ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
BRIEF

published on 10/03/2024 at 14:05, 1 year 7 months ago

Le professeur Wiltrud Treffenfeldt quitte le conseil de surveillance de BRAIN Biotech AG

Biotechnologie Démission Conseil De Surveillance BRAIN Biotech SA Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 1 year 7 months ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 1 year 7 months ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes
BRIEF

published on 09/20/2024 at 19:55, 1 year 7 months ago

BRAIN Biotech AG conclut un accord de 128,88 millions d'euros avec Royalty Pharma

BRAIN Biotech SA Financement Non Dilutif Monétisation Des Redevances Composé Expérimental Enzymes Industrielles
BRIEF

published on 09/20/2024 at 19:52, 1 year 7 months ago

BRAIN Biotech AG Secures Royalty Monetization Deal Worth Up to EUR 128.88 Million

BRAIN Biotech Royalty Monetization Deucrictibant Royalty Pharma Hereditary Angioedema

Accesswire

Published on 05/14/2026 at 15:10, 1 hour 46 minutes ago

Banyan Provides Summary of 2025 Diamond Drill Program for the Flagship AurMac Project, Yukon, Canada
Published on 05/14/2026 at 15:00, 1 hour 56 minutes ago

Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 1 hour 56 minutes ago

ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders
Published on 05/14/2026 at 14:50, 2 hours 6 minutes ago

Germany's BGR Assesses NextSource Materials' Molo Graphite Mine as Part of Federal Critical Minerals Study
Published on 05/14/2026 at 14:30, 2 hours 26 minutes ago

Boron One Holdings Inc. Completes Its Jarandol Basin Exploration Program for 2026

View all ACCESSWIRE

EQS Group

Published on 05/14/2026 at 16:15, 40 minutes ago

Fibank successfully closed a record-breaking international placement for a Bulgarian bank, raising a total of EUR 310 million across two bond issues
Published on 05/14/2026 at 14:55, 2 hours ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 2 hours 1 minute ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/14/2026 at 14:53, 2 hours 2 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 05/14/2026 at 14:53, 2 hours 2 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 05/14/2026 at 09:03, 7 hours 53 minutes ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 22 hours 53 minutes ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 22 hours 56 minutes ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 22 hours 56 minutes ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 22 hours 56 minutes ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires

View all LES ECHOS COMFI WIRE